Barbarian At The Gate: Zoetis (ZTS)

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Zoetis ( ZTS) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate. In addition to specific proprietary factors, Trade-Ideas identified Zoetis as such a stock due to the following factors:

  • ZTS has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $126.2 million.
  • ZTS has traded 1.2 million shares today.
  • ZTS traded in a range 291.9% of the normal price range with a price range of $1.94.
  • ZTS traded above its daily resistance level (quality: 530 days, meaning that the stock is crossing a resistance level set by the last 530 calendar days. The resistance price is defined by the Price - $0.01 at the time of the signal).

Stocks matching the 'Barbarian at the Gate' criteria are worthwhile stocks to watch for a variety of factors including historical back testing and volatility. Trade-Ideas targets these opportunities because the stock is exhibiting an unusual behavior while displaying positive price action. In this case, the stock crossed an important inflection point; namely, 'resistance' while at the same time the range of the stock's movement in price is more than twice its normal size. This large range foreshadows a possible continuation as the stock moves higher.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in ZTS with the Ticky from Trade-Ideas. See the FREE profile for ZTS NOW at Trade-Ideas

More details on ZTS:

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals worldwide. The stock currently has a dividend yield of 0.9%. ZTS has a PE ratio of 31.

The average volume for Zoetis has been 2.8 million shares per day over the past 30 days. Zoetis has a market cap of $18.9 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.81 and a short float of 1% with 2.82 days to cover. Shares are up 15.2% year-to-date as of the close of trading on Monday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Here Are the 3 Biggest Market Movers Monday

Here Are the 3 Biggest Market Movers Monday

Learn Options Trading from the Najarian Brothers, the Best in the Business

Learn Options Trading from the Najarian Brothers, the Best in the Business

Dow Loses Steam as Yields Hover Near 3% Threshold

Dow Loses Steam as Yields Hover Near 3% Threshold

Jim Cramer: Kimberly Clark's Quarter Was Better Than Procter & Gamble's

Jim Cramer: Kimberly Clark's Quarter Was Better Than Procter & Gamble's

The Stock Market Isn't Rigged, Just Look At The Odds (VIDEO)

The Stock Market Isn't Rigged, Just Look At The Odds (VIDEO)